Ideas
The stock has drawn down significantly (cited as falling from ~$80 to ~$17), trading at ~9x EV/EBITDA and an 11% Free Cash Flow yield, with an 80% ROIC due to its asset-light, outsourced manufacturing model. The market has likely over-penalized the stock due to GLP-1 weight-loss drug fears or momentum selling. However, the "Premier Protein" brand has strong distribution and sticky demand (protein is essential regardless of weight loss methods), creating a dislocation between price and business quality. LONG (Deep Value). Competition from private labels (e.g., Costco/Kirkland); single-category reliance; potential impact of GLP-1s on consumption habits.
The Equal Weight S&P 500 has historically outperformed the Market Cap Weighted S&P 500 over the long run, but has significantly lagged recently due to the concentration of returns in the "Mag 7." Markets are cyclical; if the "rolling mania" in large-cap tech fades, capital will rotate back into the broader market (small/mid-caps and value), causing Equal Weight indices to outperform the top-heavy SPY. LONG (Relative to SPY). Continued momentum in mega-cap tech; structural shift favoring "winner-take-all" tech monopolies.
Moody's operates as a duopoly (with S&P) controlling 80% of the credit rating market, boasting 51% operating margins. The stock is down ~22% YTD due to fears that AI will disrupt its analytics business (40% of revenue). The core ratings business (60% of revenue) is a regulatory "toll bridge" that is legally mandated and unlikely to be disrupted by AI. The sell-off provides a rare entry point into a high-quality compounder, even if the P/E remains elevated at ~34x. LONG (Quality Compounder). Valuation compression (trading at 34x P/E); regulatory changes; cyclical downturn in bond issuance volumes; AI successfully eroding the analytics moat.
Berkshire holds a massive cash/treasury position (~$167B+) and trades around $497 against an estimated intrinsic value of ~$550 (based on a sum-of-the-parts valuation: 17x operating earnings + cash/equities). In a market characterized by "lofty valuations," Berkshire acts as an anti-fragile "placeholder for cash." Its fortress balance sheet allows it to deploy capital when others are distressed, providing downside protection that the S&P 500 lacks. LONG (Safe Haven / Compounder). Size impedes high growth; conglomerate discount may persist; loss of Buffett (key man risk, though mitigated by succession plan).
This We Study Billionaires video, published February 28, 2026,
features Tobias Carlisle, Hari Ramachandra, Stig Brodersen
discussing BRBR, RSP, MCO, BRK.B.
4 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Tobias Carlisle,
Hari Ramachandra,
Stig Brodersen
· Tickers:
BRBR,
RSP,
MCO,
BRK.B